One of the many reasons we celebrate #OCTober? The ability to see treatment impact with greater clarity.¹ OCT-guided PCI has been shown to achieve larger stent area and greater stent expansion, while reducing procedural complications.2 With Compare Pullbacks in Ultreon 3.0 Software, physicians can synchronize and scroll through two pullbacks side by side, helping visualize treatment impact and evaluate results with greater clarity.1,3 See how #Ultreon 3.0 Software brings clarity to OCT imaging in complex coronary cases: https://bit.ly/4gUGSRH U.S. Safety Info: bit.ly/UltreonPlatformISI #OCTimaging
About us
At Abbott, we’re keeping people healthy with innovative medical device technologies that help advance the future of cardiovascular care and improve patient lives. With essential devices, next-generation technologies, and dedicated patient research, we’re improving the patient experience and helping lay the foundation for better health outcomes by offering efficient and effective disease management for a range of cardiovascular conditions. View our full cardiovascular product portfolio at: https://www.cardiovascular.abbott/us/en/hcp/products.html Access video resources covering product information, training, clinical evidence, clinical use cases and patient experiences at: https://www.youtube.com/@AbbottCardiovascular
- Website
-
https://www.cardiovascular.abbott/
External link for Abbott | Cardiovascular
- Industry
- Medical Device
- Company size
- 5,001-10,000 employees
- Specialties
- Cardiology, Electrophysiology, Cardiac Rhythm Management, Pacemakers, Insertable Cardiac Monitors, Structural Heart, Cardiac Mapping, Medical Devices, Transcatheter Valve Therapies, Structural Interventions, Intravascular Imaging, Vessel Closure, Atherectomy, Cardiac Surgery, and Peripheral Intervention
Updates
-
It’s time for an #OCTober challenge! Put your OCT interpretation skills to the test and see how your assessment compares to the AI-automated insights and instant measurements in #Ultreon 3.0 Software. Challenge: Which one of these do you see in this post-PCI cross-section? ● Medial Dissection ● Stent Malapposition ● Underexpansion ● Intramural Hematoma Drop your answer in the comments to join the discussion and be notified when we reveal the answer. Learn more: https://bit.ly/46sYPAH U.S. Safety Info: bit.ly/UltreonPlatformISI #OCTimaging #PCI
-
-
New data dropping at #TCT2026! Join us to explore the latest clinical outcomes and developments across our mitral #TEER, tricuspid TEER, and #TMVR therapies. Explore our agenda: https://abbo.tt/4iokWz2 TriClip Important Safety Info: https://lnkd.in/g3UZ2PJK Tendyne Important Safety Info: https://abbo.tt/TendyneISI
-
How much can happen in one second? This #OCTober we're highlighting how the new Fast Pullback in Ultreon 3.0 Software can complete a 75 mm OCT pullback in one-second, enabling low-to-zero contrast OCT imaging with higher resolution than IVUS.¹,² It’s now easier to acquire a good quality pullback (without blood swirl) the first time.* Reimagine imaging with #Ultreon: https://bit.ly/4gUGSRH U.S. Safety Info: bit.ly/UltreonPlatformISI *Compared to previous Ultreon or AptiVue. Data on file at Abbott.
-
Break free from one-size-fits-all solutions. Our TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ delivers tailored energy that adapts to virtually any patient, procedure*, or atrial anatomy.¹ʼ² Explore our TactiFlex Duo Ablation Catheter, SE: https://bit.ly/4h4YSHP Safety Info: https://bit.ly/4xUErob #AFib #PFA #LetsDuoIt *In accordance with the indications listed in the IFU.
-
Commit to a consistent, efficient, and predictable close. 🔒 As the world’s leading vascular closure system with a broad range of arterial and venous indications, our Perclose devices can help you achieve hemostasis across a variety of transfemoral procedures. 👤 Contact your vascular specialist to get certified. 🔍Discover the Perclose difference: http://bit.ly/4oZ0fLy Safety Info: http://bit.ly/45yQUCq #Perclose #Vascular #PatientCare
-
-
Frailty is nearly universal in patients with advanced heart failure receiving LVAD therapy — but it’s not fixed. In an analysis of 2,700+ HeartMate 3 LVAD patients: - 95% were classified as frail at baseline - Frailty was strongly associated with adverse outcomes - Within 3 months, 15% of patients recovered to a non-frail status, which was associated with a significantly lower risk of adverse events. These findings, first seen at ISHLT 2026, suggest frailty in advanced heart failure may reflect reversible physiological vulnerability, not irreversible decline. Read the full analysis in JACC: Heart Failure: https://bit.ly/4dwdFKD US Safety Info: https://bit.ly/42zc15h #HeartFailure #LVAD #ClinicalData
-
-
The 2026 #CardiacSurgery Fellows Course offered a unique opportunity for fellows to gain hands-on experience with Epic Elite in a wet lab setting, engage directly with engineers and developers, and witness the manufacturing processes and engineering testing that bring valve technologies to life. Thank you to our faculty, fellows, and Abbott teams for sharing their expertise and curiosity throughout the course. #StructuralHeart #CardioEd #HeartValve
-
-
Now, patients can order and track VAD supplies online! Our HealthCheck app makes staying on top of VAD supplies simple, with real-time order tracking, shipment updates, and an easy reordering process. This powerful healthcare tool also allows patients to submit VAD readings and photos, complete surveys, and stay connected with you and your care team through reminders and notifications. Encourage your patients to download the HealthCheck app on Apple or Android, or visit ACHHealthCheck.com. #HeartFailure #VAD
-
-
What’s on your agenda for #TCT2026? Join us in San Diego as we showcase the latest clinical research and innovation to help physicians navigate complex cases with insight and intuition — from head to toe, access to close. ✅ Attend expert-led symposia ✅ Participate in hands-on training with renowned faculty ✅ Discover the latest clinical science and breakthrough technologies ✅ Connect with peers and innovators advancing the future of cardiovascular care. Explore our program: AbbottatTCT.com